β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction-Reference-Cited by-同舟云学术

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction

Published:2017-06 Issue:22 Volume:69 Page:2710-2720
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Dondo Tatendashe B.,Hall Marlous,West Robert M.,Jernberg Tomas,Lindahl Bertil,Bueno Hector,Danchin Nicolas,Deanfield John E.,Hemingway Harry,Fox Keith A.A.,Timmis Adam D.,Gale Chris P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial;Lancet,2001

2. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction;N Engl J Med,1981

3. Overview of results of randomized clinical trials in heart disease: I. Treatments following myocardial infarction;Yusuf;JAMA,1988

4. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial;Chen;Lancet,2005

5. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological and Device-Based Intervention for Preventing Heart Failure After Acute Myocardial Infarction　― A Clinical Review ―;Circulation Journal;2024-09-13

2. Long‐Term Risk of Cardiovascular Death in Patients With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction: A Multicenter, Prospective Registry Study;Journal of the American Heart Association;2024-09-09

3. Integration of network pharmacology and proteomics analysis to identify key target pathways of Ginsenoside Re for myocardial ischemia;Phytomedicine;2024-09

4. Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial;BMJ OPEN;2024

5. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30